Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06669416 · ClinicalTrials.gov registry record · NA
Taste Alterations Study
A NA study of Taste, Altered and Chemotherapy Side Effects, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06669416 is a NA study of Taste, Altered and Chemotherapy Side Effects that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06669416, a NA study of Taste, Altered and Chemotherapy Side Effects, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The main questions it aims to answer are: 1. Does completing a standard assessment increase the detection of chemotherapy induced taste changes compared with usual care (no assessment)? What TA are experienced? Are there any patterns in TA symptom occurrence based on age, sex, race/ethnicity, cancer type, chemotherapy agent, etc. 2. Do patients take action to deal with the TA? What strategies are used? Do patients in the intervention group use the assessments to select interventions? 3. Do the interventions lessen TA symptoms and maintain food intake? Is the treatment (in-depth assessment and education) more effective in lessening the intensity of TA than usual care? Which level of assessment is needed to support symptom management to reduce symptom severity? Participants will: Complete baseline assessment before starting their initial chemotherapy infusion (all patients) Participate in baseline patient education based on assigned intervention (usual care vs. treatment) Engage in TA management between chemotherapy infusion clinic visits based on education Visit the clinic for chemotherapy infusions as scheduled; Complete TA assessments and reporting based on intervention; Work with nurse coaches to answer questions and help with the intervention. Complete study data collection on the 4th chemotherapy cycle (but continue intervention) Complete final data collection at 6 months
Conditions Studied
Interventions
- BEHAVIORAL Taste Alteration Self-Assessment
- BEHAVIORAL Taste Alternation Self-Management
Study Locations (1)
Illinois
- Advocate Illinois Masonic Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06669416
The ClinicalTrials.gov registry entry for NCT06669416 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Taste, Altered appearing as the primary indexed condition, and to 2 interventions - of which Taste Alteration Self-Assessment is the first listed.
NCT06669416 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06669416 about?
NCT06669416 is a clinical study titled "Taste Alterations Study". The main questions it aims to answer are: 1. Does completing a standard assessment increase the detection of chemotherapy induced taste changes compared with usual care (no assessment)? What TA are experienced? Are there any patterns in TA symptom occurrence based on age, sex, race/ethnicity, cance...
What is the current status of trial NCT06669416?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-12-01. Estimated completion is 2026-05.
What conditions does trial NCT06669416 study?
This clinical trial studies the following conditions: Taste, Altered, Chemotherapy Side Effects.
What interventions are being tested in trial NCT06669416?
The interventions under investigation include: Taste Alteration Self-Assessment (BEHAVIORAL), Taste Alternation Self-Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06669416?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06669416 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Taste, Altered
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.